UTHR United Therapeutics Corporation
Healthcare$571.60+0.00%OpenMarket Cap: $24.26B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$636.83
Target (Median)
$635.00
Target Range
$516.00 - $735.00
Upside from current price: 11.4%
Rating Distribution
3 Strong Buy9 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | Wells Fargo | upgrade | Overweight | Equal Weight |
| 2026-05-07 | RBC Capital | maintain | Outperform | Outperform |
| 2026-04-10 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-03-31 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-31 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-03-31 | B of A Securities | maintain | Neutral | Neutral |
| 2026-03-30 | TD Cowen | maintain | Buy | Buy |
| 2026-03-12 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2026-03-05 | UBS | maintain | Buy | Buy |
| 2026-02-26 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $33.03 | $3.70B | 11 |
| Sun Dec 31 | $39.16 | $4.27B | 10 |
| Mon Dec 31 | $47.30 | $5.13B | 4 |
| Tue Dec 31 | $56.84 | $6.19B | 4 |